People with a rare disease have equitable access to treatments when recommended by each nation's health and care guidance body. Access to new treatments is subject to nation-specific commissioning ...
People aged 16 or over with suspected sepsis outside acute settings are assessed face-to-face using a structured set of observations, which could include those used to calculate an early warning score ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results